Post-approval studies (Phase 4)Study completedNCT02856919
What this trial is testing
A Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Once Daily Mirvaso® Gel in Patients With Chronic Persistent Vascular Facial Erythema.
Who this might be right for
Chronic Persistent Vascular Facial Erythema
Galderma Brasil Ltda. 101